A Phenotypic Screening Technology Aimed at Drugging Undruggable Targets

Date:

Tuesday, February 23, 2016, 2:00pm to 3:00pm

Dana-Farber Cancer Institute, Yawkey 308, 450 Brookline Avenue, Boston, MA

Guest speaker:
Chris Torrance, PhD
CEO and Co-founder
PhoreMost, Ltd.
Cambridge, UK

421 KB